Chemical Compound
Sulpiride; Benzamide, 5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-; o-Anisamide, N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl- (8CI); Abilit; Aiglonyl; Coolspan; DL-Sulpiride; Dobren; Dogmatil; Dogmatyl; Dolmatil; Eglonyl; Guastil; Meresa; Miradol; Mirbanil; Misulvan; N-(1-Ethyl-2-pyrrolidinylmethyl)-2-methoxy-5-sulfamidobenzamide; N-(1-Ethylpyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoylbenzamide; N-[(1-Ethyl-2-pyrrolidinyl)methyl]-2-methoxy-5-sulfamoylbenzamide; N-[(1-Ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-o-anisamide; Neogama; Omperan; Pyrikappl; RD 1403; Sernevin; Splotin; Sulpirid; Sulpitil; Sulpyrid; Sursumid; Synedil; Trilan; dl-Sulpiride; (+/-)-Sulpiride
CAS Registry Number
15676-16-1
Primary record
Sulpiride; Benzamide, 5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-; o-Anisamide, N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl- (8CI); Abilit; Aiglonyl; Coolspan; DL-Sulpiride; Dobren; Dogmatil; Dogmatyl; Dolmatil; Eglonyl; Guastil; Meresa; Miradol; Mirbanil; Misulvan; N-(1-Ethyl-2-pyrrolidinylmethyl)-2-methoxy-5-sulfamidobenzamide; N-(1-Ethylpyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoylbenzamide; N-[(1-Ethyl-2-pyrrolidinyl)methyl]-2-methoxy-5-sulfamoylbenzamide; N-[(1-Ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-o-anisamide; Neogama; Omperan; Pyrikappl; RD 1403; Sernevin; Splotin; Sulpirid; Sulpitil; Sulpyrid; Sursumid; Synedil; Trilan; dl-Sulpiride; (+/-)-Sulpiride
- 库存
- 1,662 克
- 纯度
- 99.5 %
- CAS
- 15676-16-1
化合物标识与属性
- CAS
- 15676-16-1
- PubChem CID
- 5355
- SMILES
- CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC
- Canonical SMILES
- CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC
名称与同义词
- sulpiride
- Levosulpiride
- Sulpyrid
- Sulpirid
- Aiglonyl
- Dogmatil
- Dolmatil
- Dogmatyl
- Guastil
- Abilit
- Coolspan
- Mirbanil
- Misulvan
- Sursumid
- Miradol
- Neogama
- Omperan
- Splotin
- (+/-)-Sulpiride
- Dobren
- Meresa
- Sernevin
- Eglonyl
- Sulpitil
- Trilan
- Pyrikappl
- Sulpirida
- Psicocen
- Pyrkappl
- Synedil
- 15676-16-1
- Calmoflorine
- Championyl
- Lisopiride
- Stamonevrol
- Sulpiridum
- Mariastel
- Norestran
- Ozoderpin
- Alimoral
- Darleton
- Desmenat
- Eclorion
- Eusulpid
- Fardalan
- Isnamide
- Kylistro
- Zemorcon
- Dresent
- Eglonil
- Equilid
- Fidelan
- Nufarol
- Restful
- Suprium
- Valirem
- Enimon
- Normum
- Omiryl
- Sulpor
- Sulperide
- Levopraid
- vertigo neogama
- vertigo-neogama
- dl-sulpiride
- Sulp
- Vertigo Meresa
- Vertigo-Meresa
- (RS)-(+/-)-sulpiride
- Deponerton
- Desisulpid
- Youmathyle
- Lebopride
- Levobren
- Margenol
- Nichimal
- Pontiride
- Skanozen
- Sulpivert
- Sulpride
- Arminol
- Betamac
- Tepavil
- Digton
- Ekilid
- Keityl
- Seeglu
- (+-)-sulpiride
- rac Sulpiride
- Milsulvan;
- Dogmatil;
- Dogmatyl;
- Mirbanil;
- L-Sulpiride
- Sulpiride-R
- Sulpiridum [INN-Latin]
- Levosulpiride [INN]
- Sulpirida [INN-Spanish]
- Sulpiride CRS
- Compound 7
- (y)-Sulpiride
- Sulpiride, SLP
- (plusmn)-sulpiride
- Dogmatyl (TN)
- (?)-Sulpiride
- Prestwick_431
- S-(-)-Sulpiride-d3
- (??)-Sulpiride
- S-(-)-Sulpiride
- (S)-(-)-sulpiride
- Sulpiride (Standard)
- CHEMBL26
- Levosulpiridum [INN-Latin]
- Levosulpirida [INN-Spanish]
- PS30 - Sulpiride
- RefChem:56075
- SULPIRIDE [INN]
- SULPIRIDE [JAN]
- DTXSID1042574
- SULPIRIDE [MI]
- C15H23N3O4S
- SULPIRIDE [USAN]
- (.+/-.)-Sulpiride
- Prestwick0_000056
- Prestwick1_000056
- Prestwick2_000056
- Prestwick3_000056
- CCRIS 4248
- BGRJTUBHPOOWDU-UHFFFAOYSA-N
- N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide
- SULPIRIDE,(+)
- SULPIRIDE,(-)
- RD 1403
- Biomol-NT_000037
- Biomol-NT_000162
- SULPIRIDE [MART.]
- UNII-7MNE9M8287
- N05AL01
- SCHEMBL8421
- SULPIRIDE [WHO-DD]
- CCRIS-4248
- 7MNE9M8287
- Sulpiride [USAN:INN:BAN:JAN]
- Lopac0_001050
- MFCD00055061
- Oprea1_602476
- BSPBio_000211
- DTXCID9022574
- (RS)-(A+/-)-Sulpiride
- CHEBI:32168
- MLS000069434
- MLS001306443
- DivK1c_000278
- EINECS 239-753-7
- SPBio_002132
- AC1L1K62
- BPBio1_000233
- BPBio1_000463
- BPBio1_001255
- GTPL5501
- orb1309432
- orb3025058
- Sulpiride (JP18/USAN/INN)
- SULPIRIDE [EP IMPURITY]
- Magnetic resonance imaging sulpiride
- NSC-757850
- SCHEMBL29359128
- SULPIRIDE [EP MONOGRAPH]
- BDBM11638
- CTK8F2082
- ERK5-2H07
- HMS500N20
- HY-B1019R
- KBio1_000278
- KS-00000YBQ
- RD-1403
- BRN 0494008
- CID5355
- R.D. 1403
- NINDS_000278
- s4655
- Sulpiride [USAN:BAN:INN:JAN]
- Sulpiride 1.0 mg/ml in Methanol
- HMS1568K13
- HMS2095K13
- HMS2231K07
- HMS3263A22
- HMS3266P12
- HMS3371P16
- HMS3372O01
- HMS3393A08
- HMS3411D18
- HMS3651G12
- HMS3675D18
- HMS3712K13
- HMS3885J14
- HMS5080O10
- HMS5083A10
- 23672-07-3
- BCP04500
- BCP13871
- CID:5355
- HY-B1019
- MSK10053
- N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide
- STR09321
- ( inverted question mark)-Sulpiride
- Tox21_302205
- Tox21_501050
- C15-H23-N3-O4-S
- EBC-09094
- HB1835
- STK368596
- AKOS004912732
- AN-1017
- AN-1019
- CCG-205127
- CS-4534
- CS-O-02320
- DB00391
- FS27973
- J3.446K
- LP01050
- NSC 757850
- SDCCGSBI-0051020.P002
- ( inverted exclamation markA)-Sulpiride
- 5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide
- IDI1_000278
- N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide
- NCGC00015966-03
- NCGC00015966-04
- NCGC00015966-05
- NCGC00015966-06
- NCGC00015966-07
- NCGC00015966-08
- NCGC00015966-16
- NCGC00024852-02
- NCGC00024852-03
- NCGC00024852-04
- NCGC00024852-05
- NCGC00255813-01
- NCGC00261735-01
- AC-12181
- AK163543
- LS-20058
- LS-20059
- RV-12309
- SID:53789539
- SMR000038923
- SY235220
- 3-PERFLUOROBUTYL-1,2-EPOXYPROPANE
- AB0105833
- CAS-15676-16-1
- DB-046215
- o-Anisamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-
- Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-
- EU-0001755
- EU-0101050
- FT-0630504
- FT-0652244
- FT-0674703
- n-((1-ethylpyrrolidin-2-yl)methyl)-2-methoxy-5-sulfamoylbenzamide
- NS00010476
- R. D. 1403
- S0501
- 5-22-08-00105 (Beilstein Handbook Reference)
- N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoyl-benzamide
- D01226
- J10067
- S 8010
- EN300-2010446
- 676S161
- A809768
- D013469
- L000579
- Q422418
- SR-01000075402
- Benzamide, 5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-
- I06-0054
- SR-01000075402-2
- SR-01000075402-3
- SR-01000075402-6
- BRD-A55272860-001-03-9
- BRD-A55272860-001-04-7
- BRD-A55272860-001-08-8
- BRD-A55272860-001-14-6
- BRD-A55272860-001-15-3
- Z84655412
- Sulpiride, British Pharmacopoeia (BP) Reference Standard
- 1-ethyl-2-(2-methoxy-5-sulfamoylbenzamidomethyl)pyrrolidine
- N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-o-anisamide
- Sulpiride, European Pharmacopoeia (EP) Reference Standard
- (+)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoyl-benzamide
- 124020-27-5
- 5-(Aminosufonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide
- 5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-benzamide
- 5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide
- Benzamide, 5-(aminosulfonyl)-N-[(1-ethyl- 2-pyrrolidinyl)methyl]-2-methoxy-
- N-(1-ETHYL-2-PYRROLIDINYLMETHYL)-2-METHOXY-5-SULFAMIDOBENZAMIDE
- o-Anisamide, N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-
- N-(((S)-1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide
- N-((1-ethylpyrrolidin-2-yl)methyl)-2-methoxy-5-sulfamoyl-benzamide
- N-(1-Ethyl-pyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoyl-benzamide
- N-(1-Ethylpyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoylbenzamide
- N-[(1-Ethyl-2-pyrrolidinyl)methyl]-2-methoxy-5-sulfamoylbenzamide
- N-[(1-Ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-2-methoxybenzamide
- N-1-(Ethylpyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoylbenzamide
- (+/-)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide
- (-)-N-(((S)-1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide
- (S)-(-)-N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide
- (S)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide
- (S)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-methoxy-5-sulfamoylbenzamide
- Benzamida, 5-(aminosulfonil)-N-[(1-etil-2-pirrolidinil) metil]-2-metoxi-
- Benzamide,5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-
- N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-methoxy-5-sulfamoylbenzamide
- S-(-)-N-(1-Ethyl-2-pyrrolidinomethyl)-2-methoxy-5-sulfamoylebenzamide
- (+/-)-5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide
- (RS)-(+/-)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide
- 5-(Aminosulfonyl)-N-[(1-ethyl-2- pyrrolidinyl)methyl]-2-methoxy- benzamide
- Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-, (S)-
- Benzamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoyl-, S-(-)-
- o-ANISAMIDE, N-((1-ETHYL-2-PYRROLIDINYL)METHYL)-5-SULFAMOYL-, (S)-(-)-
- ( inverted question mark)-5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide
- 239-753-7
- Sulpiride; Benzamide, 5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-; o-Anisamide, N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl- (8CI); Abilit; Aiglonyl; Coolspan; DL-Sulpiride; Dobren; Dogmatil; Dogmatyl; Dolmatil; Eglonyl; Guastil; Meresa; Miradol; Mirbanil; Misulvan; N-(1-Ethyl-2-pyrrolidinylmethyl)-2-methoxy-5-sulfamidobenzamide; N-(1-Ethylpyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoylbenzamide; N-[(1-Ethyl-2-pyrrolidinyl)methyl]-2-methoxy-5-sulfamoylbenzamide; N-[(1-Ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-o-anisamide; Neogama; Omperan; Pyrikappl; RD 1403; Sernevin; Splotin; Sulpirid; Sulpitil; Sulpyrid; Sursumid; Synedil; Trilan; dl-Sulpiride; (+/-)-Sulpiride